248 related articles for article (PubMed ID: 31405857)
1. Shock and Early Death in Hematologic Patients with Febrile Neutropenia.
Guarana M; Nucci M; Nouér SA
Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31405857
[TBL] [Abstract][Full Text] [Related]
2. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A
Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741
[TBL] [Abstract][Full Text] [Related]
3. Pediatric fever in neutropenia with bacteremia-Pathogen distribution and in vitro antibiotic susceptibility patterns over time in a retrospective single-center cohort study.
Stergiotis M; Ammann RA; Droz S; Koenig C; Agyeman PKA
PLoS One; 2021; 16(2):e0246654. PubMed ID: 33577566
[TBL] [Abstract][Full Text] [Related]
4. Associated factors and clinical outcomes of bloodstream infection due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae during febrile neutropenia.
Ben-Chetrit E; Eldaim MA; Bar-Meir M; Dodin M; Katz DE
Int J Antimicrob Agents; 2019 Apr; 53(4):423-428. PubMed ID: 30572008
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology and source of infection in cancer patients with febrile neutropenia: an experience from a developing country.
Joudeh N; Sawafta E; Abu Taha A; Hamed Allah M; Amer R; Odeh RY; Salameh H; Sabateen A; Aiesh BM; Zyoud SH
BMC Infect Dis; 2023 Feb; 23(1):106. PubMed ID: 36814229
[TBL] [Abstract][Full Text] [Related]
6. Pediatric Febrile Neutropenia: Change in Etiology of Bacteremia, Empiric Choice of Therapy and Clinical Outcomes.
Alali M; David MZ; Danziger-Isakov LA; Elmuti L; Bhagat PH; Bartlett AH
J Pediatr Hematol Oncol; 2020 Aug; 42(6):e445-e451. PubMed ID: 32404688
[TBL] [Abstract][Full Text] [Related]
7. The relationship between mortality and microbiological parameters in febrile neutropenic patients with hematological malignancies.
Calik S; Ari A; Bilgir O; Cetintepe T; Yis R; Sonmez U; Tosun S
Saudi Med J; 2018 Sep; 39(9):878-885. PubMed ID: 30251730
[TBL] [Abstract][Full Text] [Related]
8. Low utilization of vancomycin in febrile neutropenia: real-world evidence from 4 Brazilian centers.
Ramos JF; Pereira AD; Seiwald MCN; Gandolpho LS; Molla VC; Guaraná M; Nouér SA; Nucci M; Rodrigues CA
Support Care Cancer; 2023 Nov; 31(12):687. PubMed ID: 37947888
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic susceptibility of Gram-negatives isolated from bacteremia in children with cancer. Implications for empirical therapy of febrile neutropenia.
Castagnola E; Caviglia I; Pescetto L; Bagnasco F; Haupt R; Bandettini R
Future Microbiol; 2015; 10(3):357-64. PubMed ID: 25812459
[TBL] [Abstract][Full Text] [Related]
10. Health-care associated bacteremia in geriatric cancer patients with febrile neutropenia.
Aydemir H; Piskin N; Kokturk F; Gökmen A; Akduman D
J Geriatr Oncol; 2013 Apr; 4(2):190-5. PubMed ID: 24071544
[TBL] [Abstract][Full Text] [Related]
11. Early discontinuation of empirical antibacterial therapy in febrile neutropenia: the ANTIBIOSTOP study.
Le Clech L; Talarmin JP; Couturier MA; Ianotto JC; Nicol C; Le Calloch R; Dos Santos S; Hutin P; Tandé D; Cogulet V; Berthou C; Guillerm G
Infect Dis (Lond); 2018 Jul; 50(7):539-549. PubMed ID: 29451055
[TBL] [Abstract][Full Text] [Related]
12. Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in febrile neutropenic children.
Han SB; Jung SW; Bae EY; Lee JW; Lee DG; Chung NG; Jeong DC; Cho B; Kang JH; Kim HK; Park YJ
Microb Drug Resist; 2015 Apr; 21(2):244-51. PubMed ID: 25398058
[TBL] [Abstract][Full Text] [Related]
13. The epidemiology of bacteremia with febrile neutropenia: experience from a single center, 1988-2004.
Paul M; Gafter-Gvili A; Leibovici L; Bishara J; Levy I; Yaniv I; Shalit I; Samra Z; Pitlik S; Konigsberger H; Weinberger M
Isr Med Assoc J; 2007 Jun; 9(6):424-9. PubMed ID: 17642387
[TBL] [Abstract][Full Text] [Related]
14. Daptomycin vs. glycopeptides in the treatment of febrile neutropenia: results of the Izmir matched cohort study.
Sipahi OR; Kahraman H; Erdem HA; Yetkin F; Kaya S; Demirdal T; Tunccan OG; Karasahin O; Oruc E; Cag Y; Kurtaran B; Ulug M; Kutlu M; Avci M; Oztoprak N; Arda B; Pullukcu H; Tasbakan M; Yamazhan T; Kandemir O; Dizbay M; Sipahi H; Ulusoy S
Infection; 2019 Apr; 47(2):259-266. PubMed ID: 30498901
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for adverse outcomes and multidrug-resistant Gram-negative bacteraemia in haematology patients with febrile neutropenia in a Singaporean university hospital.
Poon LM; Jin J; Chee YL; Ding Y; Lee YM; Chng WJ; Chai LY; Tan LK; Hsu LY
Singapore Med J; 2012 Nov; 53(11):720-5. PubMed ID: 23192498
[TBL] [Abstract][Full Text] [Related]
16. A change for the antibacterial treatment policy to decrease carbapenem consumption at a haematopoietic stem cell transplantation centre.
Metan G; Kaynar L; Yozgat N; Elmali F; Kürkçüoglu CA; Alp E; Çetin M
Infez Med; 2017 Mar; 25(1):33-37. PubMed ID: 28353453
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a risk-guided strategy for empirical carbapenem use in febrile neutropenia.
Khoo AL; Zhao YJ; Teng M; Ying D; Jin J; Chee YL; Poon LM; Lim SE; Koh LP; Chng WJ; Lim BP; Hsu LY; Chai LYA
Int J Antimicrob Agents; 2018 Sep; 52(3):350-357. PubMed ID: 29751120
[TBL] [Abstract][Full Text] [Related]
18. Is current initial empirical antibiotherapy appropriate to treat bloodstream infections in short-duration chemo-induced febrile neutropenia?
Joncour A; Puyade M; Michaud A; Tourani JM; Cazenave-Roblot F; Rammaert B
Support Care Cancer; 2020 Jul; 28(7):3103-3111. PubMed ID: 31667604
[TBL] [Abstract][Full Text] [Related]
19. Limiting Vancomycin Exposure in Pediatric Oncology Patients With Febrile Neutropenia May Be Associated With Decreased Vancomycin-Resistant Enterococcus Incidence.
Karandikar MV; Milliren CE; Zaboulian R; Peiris P; Sharma T; Place AE; Sandora TJ
J Pediatric Infect Dis Soc; 2020 Sep; 9(4):428-436. PubMed ID: 31603472
[TBL] [Abstract][Full Text] [Related]
20. Current time-to-positivity of blood cultures in febrile neutropenia: a tool to be used in stewardship de-escalation strategies.
Puerta-Alcalde P; Cardozo C; Suárez-Lledó M; Rodríguez-Núñez O; Morata L; Fehér C; Marco F; Del Río A; Martínez JA; Mensa J; Rovira M; Esteve J; Soriano A; Garcia-Vidal C
Clin Microbiol Infect; 2019 Apr; 25(4):447-453. PubMed ID: 30096417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]